FDA recall D-0094-2026

GenoGenix LLC · Class I · drug

Product

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Reason for recall

Microbial Contamination of Sterile Products: elevated endotoxin levels

Distribution

US Nationwide.

Key facts

Status
Ongoing
Initiation date
2025-07-30
Report date
2025-10-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Boca Raton, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0094-2026